Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950124-05-002442
Filing Date
2005-04-15
Accepted
2005-04-15 16:16:54
Documents
15
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v07515e10vk.htm 10-K 970980
2 EXHIBIT 10.35 v07515exv10w35.txt EX-10.35 19522
3 EXHIBIT 10.36 v07515exv10w36.txt EX-10.36 2790
4 EXHIBIT 10.37 v07515exv10w37.txt EX-10.37 18082
5 EXHIBIT 10.38 v07515exv10w38.txt EX-10.38 93009
6 EXHIBIT 10.39 v07515exv10w39.txt EX-10.39 29604
7 EXHIBIT 10.40 v07515exv10w40.txt EX-10.40 4041
8 EXHIBIT 10.41 v07515exv10w41.txt EX-10.41 2456
9 EXHIBIT 23.1 v07515exv23w1.txt EX-23.1 1746
10 EXHIBIT 23.2 v07515exv23w2.txt EX-23.2 1522
11 EXHIBIT 31.1 v07515exv31w1.txt EX-31.1 4092
12 EXHIBIT 31.2 v07515exv31w2.txt EX-31.2 4132
13 EXHIBIT 32.1 v07515exv32w1.txt EX-32.1 1131
14 EXHIBIT 32.2 v07515exv32w2.txt EX-32.2 1199
15 GRAPHIC v07515v0751502.gif GRAPHIC 4145
  Complete submission text file 0000950124-05-002442.txt   1161507
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33393 | Film No.: 05753927
SIC: 2834 Pharmaceutical Preparations